CN105254615B - 苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 - Google Patents
苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 Download PDFInfo
- Publication number
- CN105254615B CN105254615B CN201510405448.6A CN201510405448A CN105254615B CN 105254615 B CN105254615 B CN 105254615B CN 201510405448 A CN201510405448 A CN 201510405448A CN 105254615 B CN105254615 B CN 105254615B
- Authority
- CN
- China
- Prior art keywords
- compound
- och
- cancer
- formula
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510405448.6A CN105254615B (zh) | 2014-07-11 | 2015-07-09 | 苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2014103321856 | 2014-07-11 | ||
CN201410332185 | 2014-07-11 | ||
CN201510405448.6A CN105254615B (zh) | 2014-07-11 | 2015-07-09 | 苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105254615A CN105254615A (zh) | 2016-01-20 |
CN105254615B true CN105254615B (zh) | 2017-02-22 |
Family
ID=55094604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510405448.6A Active CN105254615B (zh) | 2014-07-11 | 2015-07-09 | 苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105254615B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111170998B (zh) | 2014-11-05 | 2023-04-11 | 益方生物科技(上海)股份有限公司 | 嘧啶或吡啶类化合物、其制备方法和医药用途 |
US10513509B2 (en) | 2016-05-26 | 2019-12-24 | Recurium Ip Holdings, Llc | EGFR inhibitor compounds |
CN107840846B (zh) * | 2016-09-19 | 2020-11-24 | 郑州泰基鸿诺医药股份有限公司 | 一种含嘧啶环的化合物、egfr抑制剂及其应用 |
WO2019010619A1 (zh) * | 2017-07-10 | 2019-01-17 | 焦玉奇 | 2-(2,4,5-取代苯胺)嘧啶衍生物 |
CN108558832B (zh) * | 2018-01-17 | 2021-04-30 | 浙江树人学院 | 一种新型抗肿瘤药物奥希替尼衍生物及其制备方法 |
CN108658943B (zh) * | 2018-06-08 | 2021-04-30 | 浙江树人学院 | 一种具有抗肿瘤活性的苯基磺胺类化合物及其制备和应用 |
CN110857292A (zh) * | 2018-08-22 | 2020-03-03 | 上海艾力斯医药科技有限公司 | 一种egfr激酶抑制剂及其制备方法和应用 |
CN111747931A (zh) * | 2019-03-29 | 2020-10-09 | 深圳福沃药业有限公司 | 用于治疗癌症的氮杂芳环酰胺衍生物 |
CN110684016A (zh) * | 2019-09-27 | 2020-01-14 | 上海应用技术大学 | 一种含氟的azd9291衍生物及其制备方法和应用 |
CN112645934A (zh) * | 2020-12-25 | 2021-04-13 | 中山奕安泰医药科技有限公司 | 奥斯替尼中间体及其精制方法 |
CN115677666A (zh) * | 2021-07-30 | 2023-02-03 | 上海艾力斯医药科技股份有限公司 | 一种吲哚联嘧啶类化合物、其中间体、制备方法及其应用 |
CN116407540A (zh) * | 2023-02-17 | 2023-07-11 | 杭州邦顺制药有限公司 | 药物在预防和治疗her2表达阳性实体瘤中的应用 |
CN115819406B (zh) * | 2023-02-24 | 2023-06-02 | 淄博百极荣创医药科技有限公司 | 3-(4-嘧啶)-1h-吲哚类化合物的合成方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2881993C (en) * | 2011-07-27 | 2017-05-09 | Astrazeneca Ab | Substituted 4-methoxy-n3-(pyrimidin-2-yl)benzene-1,3-diamine compounds, and salts thereof |
-
2015
- 2015-07-09 CN CN201510405448.6A patent/CN105254615B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105254615A (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105254615B (zh) | 苯胺嘧啶衍生物及其在制备抗恶性肿瘤药物中的用途 | |
CN105461695B (zh) | 嘧啶或三嗪衍生物及其制备方法和用途 | |
EP3216786B1 (en) | Pyrimidine compounds, preparation method therefor and pharmaceutical uses thereof | |
CN102838590B (zh) | 氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途 | |
CN106928150B (zh) | 丙烯酰胺苯胺衍生物及其药学上的应用 | |
CN104140418A (zh) | 新的2-(2,4,5-取代苯胺)嘧啶衍生物及其用途 | |
BR112016007396B1 (pt) | Composto de fórmula (ii), seu processo de preparação e seu uso, composto de fórmula(iia) e composição farmacêutica | |
CN106995437A (zh) | 取代吲哚或吲唑嘧啶衍生物及其制备方法和用途 | |
CN105980377B (zh) | 作为egfr-t790m激酶抑制剂的取代的嘧啶类化合物 | |
CN104292170A (zh) | 具有抗肿瘤作用的喹唑啉-芳基脲衍生物及其应用 | |
CN103450152B (zh) | 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物 | |
CN107759600A (zh) | 作为jak抑制剂的吡咯并嘧啶化合物的结晶 | |
CN107151240A (zh) | 一类多取代喹诺酮类化合物及其制备方法和用途 | |
CN104211632A (zh) | 具有酪氨酸激酶抑制活性的2-吲哚酮衍生物及其制备方法与应用 | |
CN102066362B (zh) | 二氢吲哚酮衍生物 | |
CN106674242B (zh) | 一种具有抗肿瘤活性的莪术醇衍生物及其制备方法和应用 | |
CN105541825A (zh) | 三氮唑衍生物制备方法及其作为药物的用途 | |
CN107540661A (zh) | 作为egfr抑制剂的苯胺嘧啶化合物的结晶 | |
CN110003204A (zh) | 一种bet蛋白抑制剂、其制备方法及用途 | |
CN102153508B (zh) | 3,5-(e)-二亚苄基-n-环丙基哌啶-4-酮及其在制备治疗抗肿瘤药物中的应用 | |
CN102942529B (zh) | 4-(4-取代哌嗪)-5,6,7-三烷氧基喹唑啉类化合物及其制备方法和应用 | |
CN107383014A (zh) | 一种1H‑吡唑并[3,4‑d]嘧啶类化合物及其制备方法和应用 | |
CN110283162A (zh) | 一种新型的表皮生长因子受体抑制剂及其应用 | |
CN107513040A (zh) | 取代苯并嘧啶类化合物的制备及分子靶向肿瘤治疗药物的应用 | |
CN102153544B (zh) | 一类酪氨酸激酶抑制剂的制备及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190801 Address after: 310000 Room 3102-4, Building A, Hualian Times Building, Jianggan District, Hangzhou City, Zhejiang Province Co-patentee after: Hangzhou Ao Ao biological medicine technology Co.,Ltd. Patentee after: Hangzhou Sanyintai Pharmaceutical Technology Co.,Ltd. Address before: 310012 West Lake International Science and Technology Building C902, 391 Wenerlu, Hangzhou City, Zhejiang Province Co-patentee before: Yin Jianming Patentee before: HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200922 Address after: Room 1-906, Heda Yaogu center, 291 Fucheng Road, Xiasha street, Qiantang New District, Hangzhou City, Zhejiang Province Patentee after: Hangzhou BANGSHUN Pharmaceutical Co.,Ltd. Patentee after: Hangzhou Ao Ao biological medicine technology Co.,Ltd. Address before: 310000 Room 3102-4, Building A, Hualian Times Building, Jianggan District, Hangzhou City, Zhejiang Province Patentee before: Hangzhou Sanyintai Pharmaceutical Technology Co.,Ltd. Patentee before: Hangzhou Ao Ao biological medicine technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230419 Address after: Room 101, Building 2, No. 2069, Jinchang Road, Liangzhu Street, Yuhang District, Hangzhou, Zhejiang 311115 Patentee after: Hangzhou BANGSHUN Pharmaceutical Co.,Ltd. Address before: 310000 rooms 1-906, Heda Medicine Valley Center, 291 Fucheng Road, Xiasha street, Qiantang New District, Hangzhou City, Zhejiang Province Patentee before: Hangzhou BANGSHUN Pharmaceutical Co.,Ltd. Patentee before: Hangzhou Ao Ao biological medicine technology Co.,Ltd. |